Osmolality of Medications Administered in the Neonatal Intensive Care Unit.
作者信息
Leong Amanda, Gordon Alison, Alshaikh Belal, Yusuf Kamran, Dersch-Mills Deonne
机构信息
Pharmacy Services, Saskatchewan Health Authority, Regina, Saskatchewan.
Pharmacy Services, Alberta Health Services, Calgary, Alberta.
出版信息
Can J Hosp Pharm. 2020 Fall;73(4):288-289. Epub 2020 Oct 1.
Abstract
摘要
相似文献
1
Osmolality of Medications Administered in the Neonatal Intensive Care Unit.新生儿重症监护病房使用药物的渗透压
Can J Hosp Pharm. 2020 Fall;73(4):288-289. Epub 2020 Oct 1.
2
Osmolality of substances used in the intensive care nursery.重症监护病房所使用物质的渗透压摩尔浓度。
Pediatrics. 1983 Sep;72(3):347-52.
3
Milk as a vehicle for oral medications: hidden osmoles.牛奶作为口服药物的载体：隐藏的渗透溶质。
J Perinatol. 2012 Mar;32(3):227-9. doi: 10.1038/jp.2011.83. Epub 2011 Jun 23.
4
A New Model for Non-Lipid Compounded Neonatal Parenteral Nutrition Solution Osmolality.一种新的非脂质复合新生儿肠外营养溶液渗透压模型。
JPEN J Parenter Enteral Nutr. 2018 Aug;42(6):1075-1083. doi: 10.1002/jpen.1051. Epub 2018 Jan 7.
5
Guidelines for continuous infusion medications in the neonatal intensive care unit.
Ann Pharmacother. 1992 May;26(5):671-4. doi: 10.1177/106002809202600512.
6
Food and Drug Administration approval for medications used in the pediatric intensive care unit: a continuing conundrum.食品和药物管理局批准儿科重症监护病房使用的药物：一个持续存在的难题。
Pediatr Crit Care Med. 2011 Sep;12(5):e195-9. doi: 10.1097/PCC.0b013e3181fe25b9.
7
8
A descriptive report of end-of-life care practices occurring in two neonatal intensive care units.关于两个新生儿重症监护病房临终关怀实践的描述性报告。
Palliat Med. 2016 Dec;30(10):971-978. doi: 10.1177/0269216316634246. Epub 2016 Mar 2.
9
High alert medications administration errors in neonatal intensive care unit: A pediatric tertiary hospital experience.新生儿重症监护病房高警示药物给药错误：一家儿科三级医院的经验
Turk J Pediatr. 2018;60(3):277-285. doi: 10.24953/turkjped.2018.03.007.
10
Frequency of neurologic disorders in the neonatal intensive care unit.新生儿重症监护病房中神经系统疾病的发生率。
J Child Neurol. 1998 Sep;13(9):424-8. doi: 10.1177/088307389801300902.
引用本文的文献
1
Osmolality of compounded oral liquids for pediatrics.儿科复方口服溶液的渗透压摩尔浓度
Eur J Pediatr. 2025 Mar 14;184(4):252. doi: 10.1007/s00431-025-06080-1.
2
Development and clinical application of a stability-indicating chromatography technique for the quantification of diazoxide.一种用于定量测定二氮嗪的稳定性指示色谱技术的开发与临床应用
Heliyon. 2023 Sep 13;9(9):e20101. doi: 10.1016/j.heliyon.2023.e20101. eCollection 2023 Sep.
本文引用的文献
1
Medications That Increase Osmolality and Compromise the Safety of Enteral Feeding in Preterm Infants.增加渗透压并危及早产儿肠内喂养安全性的药物。
Neonatology. 2017;111(4):309-316. doi: 10.1159/000454667. Epub 2016 Dec 29.
2
Stability of levetiracetam in extemporaneously compounded suspensions.左乙拉西坦在临时配制混悬液中的稳定性。
Can J Hosp Pharm. 2011 May;64(3):207-11. doi: 10.4212/cjhp.v64i3.1024.
3
Milk as a vehicle for oral medications: hidden osmoles.牛奶作为口服药物的载体：隐藏的渗透溶质。
J Perinatol. 2012 Mar;32(3):227-9. doi: 10.1038/jp.2011.83. Epub 2011 Jun 23.
4
Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids.盐酸拉贝洛尔、酒石酸美托洛尔、盐酸维拉帕米和螺内酯与氢氯噻嗪在临时配制口服液体制剂中的稳定性。
Am J Health Syst Pharm. 1996 Oct 1;53(19):2304-9. doi: 10.1093/ajhp/53.19.2304.
5
Stability of citrated caffeine solutions for injectable and enteral use.注射用和肠内用枸橼酸咖啡因溶液的稳定性。
Am J Hosp Pharm. 1984 Nov;41(11):2405-6.
6
Commentary on breast-feeding and infant formulas, including proposed standards for formulas.关于母乳喂养和婴儿配方奶粉的评论，包括配方奶粉的拟议标准。
Pediatrics. 1976 Feb;57(2):278-85.
Zotero 插件